Epidemiology and susceptibility to antimicrobials in community, hospital and long-term care facility bacteremia in northern Israel: A 6 year surveillance

Israel Medical Association Journal

Volumn 11, Issue 10, 2009, Pages 592-597

  Chazan, Bibiana ^a,b   Raz, Raul ^a,c   Teitler, Nava ^a   Nitzan, Orna ^a   Edelstein, Hana ^a   Colodner, Raul ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antimicrobials; Bacteremia; Epidemiology; Resistance; Susceptibility

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERTAPENEM; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FUSIDIC ACID; GENTAMICIN; METICILLIN; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BILIARY TRACT INFECTION; BLOOD CULTURE; BONE INFECTION; CANDIDA; CATHETER INFECTION; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HEALTH CARE FACILITY; HUMAN; ISRAEL; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA; MORTALITY; PRACTICE GUIDELINE; PROTEUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SERRATIA; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS, COMMUNITY; HUMANS; ISRAEL; LENGTH OF STAY; LONG-TERM CARE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 70350678876     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med 2006; 119(6A): S20-8.
2. Cornejo-Juarez P, Velasquez-Acosta C, Diaz-Gonzalez A, Volkow-Fernandez P. Trend of antimicrobial drug-susceptibility of blood isolates at an oncological center (1998-2003). Salud Publica Mex 2005; 47: 288-293
3. Turner PJ. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002). Diagn Microbiol Infect Dis 2005; 51: 281-289
4. Oteo J, Lazaro E, Abajo FJ, Baquero F, Campos J, and Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 2005; 11(4): 546-553
5. Ortega M, Almela M, Martinez JA, et al. Epidemiology and outcome of primary community-acquired bacteremia in adult patients. Eur J Clin Microbiol Infect Dis 2007; 26: 453-457 (Pubitemid 47025031)
6. Jerassy Z, Yinnon AM, Mazouz-Cohen S, et al. Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect 2006; 62: 230-236
7. Frank M, Gur E, Givon-Lavi N, Peled N, Dagan R, Leibovitz E. Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992-2001). Scand J Infect Dis 2005; 37: 177-183
8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317 (Pubitemid 39050477)
9. Lark RL, Saint A, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2001; 41: 15-22. (Pubitemid 33001454)
10. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethroprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000; 283: 1583-1590
11. Bishara J, Livne G, Ashkenazi S, et al. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. IMAJ Isr Med Assoc J 2005; 7: 298-301. (Pubitemid 40668150)
12. Denton M. Enterobacteriaceae. Int J Antimicrob Agents 2007; 29(Suppl 3): S9-22.
13. Colodner R, Samra Z, Keller N, et al. and the Israel ESBL Group. First national surveillance of susceptibility of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel. Diagn Microbiol Infect Dis 2007; 57: 201-205 (Pubitemid 46156978)
14. European Antimicrobial Resistance Surveillance System (EARSS) Annual Report. 2006. The Netherlands, October 2007.
15. Rock W, Colodner R, Chazan B, Elias M, Raz R. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005). IMAJ Isr Med Assoc J 2007; 9: 803-805